Liminatus Pharma, Inc. (LIMN)

0.2262 -0.01 (-5.32%) USD  |  NASDAQ  |  Feb 26, 16:00
0.2331 +0.01 (+3.05%) After-Hours: 20:00
More

Liminatus Pharma Total Expenses (% of Quarterly Revenues)

Total Expenses (% of Quarterly Revenues) Chart

View Total Expenses (% of Quarterly Revenues) for LIMN.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Expenses (% of Quarterly Revenues) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Total Expenses (% of Quarterly Revenues) Range, Past 5 Years

View Total Expenses (% of Quarterly Revenues) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Expenses (% of Quarterly Revenues) Benchmarks

View Total Expenses (% of Quarterly Revenues) Benchmarks
Start Trial
CDT Equity, Inc. --
LENZ Therapeutics, Inc. Upgrade
Oruka Therapeutics, Inc. --
Maze Therapeutics, Inc. --
MapLight Therapeutics, Inc. --